Browse > Article
http://dx.doi.org/10.4333/KPS.2009.39.6.431

Comparative Superiority of in vitro Activity of DW-224a Supported by the Downward MIC Distribution in Ciprofloxacin-resistant Staphylococcus aureus  

Yoon, Eun-Jeong (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lee, Chun-Yeong (Department of Life Science, University of Seou)
Lee, Jong-Seo (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Choe, Eung-Chil (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Shim, Mi-Ja (Department of Life Science, University of Seoul)
Publication Information
Journal of Pharmaceutical Investigation / v.39, no.6, 2009 , pp. 431-435 More about this Journal
Abstract
The comparative superior in vitro activity of DW-224a was supported by the downward MIC distribution due to the weakened influence of alterations within target enzymes in ciprofloxacin-resistant Staphylococcus aureus. The MI$C_{50}$ for DW-224a was 4 $\mu$g/mL, similar to that of gemifloxacin, 8-fold less than that of sparfloxacin and 16-over-fold less than that of ciprofloxacin. We constructed combinations of amino acid changes, located at codon 80, 83 or 84 within GrlA and 84, 85 or 88 within GyrA, which were associated with MIC increase. The amino acid changes were less influential to the MIC of DW-224a compared to those of other fluoroquinolones, and it was verified from the requirement of a total of two GrlA- and two GyrA-alterations to reach the MIC of DW-224a over 32 $\mu$g/mL.
Keywords
DW-224a; DNA gyrase; Topoisomerase IV; Quinolone-resistant Staphylococus aureus (QRSA);
Citations & Related Records
연도 인용수 순위
  • Reference
1 J.M. Entenza, Y.A. Que, J. Vouillamoz, M.P. Glauser and P. Moreillon, Efficacies of moxifloxacin, ciprofloxacin and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob. Agents Chemother. 45, 3076-3083 (2001).   DOI   ScienceOn
2 J. Han, J.C. Kim, M.K. Chung, B. Kim and D.R. Choi, Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs. Biol. Pharm. Bull. 26, 832-839 (2003)   DOI   ScienceOn
3 D.C. Hooper, Mechanisms of action and resistance of older and newer quinolones. Clin. Infect. Dis. 31, S24-S28 (2000).   DOI   ScienceOn
4 F.J. Schmitz, M.E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Luckefahr, A. Fluit, J. Verihoef, U. Hadding H.P. Heinz and K. Kohrer, Characterization of grlA, grlB, gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252 (1998)
5 H.J. Yun, Y.H. Min, Y.W. Jo, M.J. Shim and E.C. Choi, Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV. Int. J. Antimicrob. Agents 25:334-337 (2005)   DOI   ScienceOn
6 M. Tanaka, T. Wang, Y. Onodera, Y. Uchida and K. Sato, Mechanisms of quinolone resistance in Staphylococcus aureus J. Infect. Chemother. 6, 131-139 (2000).   DOI   ScienceOn
7 National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Fifth Edition. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA. 11. (2000).
8 R.N. Jones, D.J. Biedenbach, P.G. Ambrose and M.A. Wikler, Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. Diagn. Microbiol. Infect. Dis. 62, 110-112 (2008).   DOI   ScienceOn
9 H.S. Park, H.J. Kim, M.J. Seol, D.R. Choi, E.C. Choi and J.H. Kwak, In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone. Antimicrob. Agents Chemother. 50, 2261 -2264 (2006).   DOI   ScienceOn
10 A.R. Kwon, Y.H. Min, J.M. Ryu, D.R. Choi, M.J. Shim and E.C. Choi, In vitro and in vivo activities of DW-224a a novel fluoroquinolone antibiotic agent. J. Antimicrob. Chemother. 58, 684 -688 (2006).   DOI   ScienceOn